Cargando…
The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer
Carcinoembryonic antigen (CEA) levels and imaging are used to guide treatment for metastatic colorectal cancer (mCRC). This study evaluated changes in CEA and imaging findings in mCRC patients following systemic therapy and their clinical significance, especially the ones with inconsistent results o...
Autores principales: | Su, Yi-Tien, Chen, Jia-Wan, Chang, Shih-Ching, Jiang, Jeng-Kai, Huang, Sheng-Chieh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684139/ https://www.ncbi.nlm.nih.gov/pubmed/36418865 http://dx.doi.org/10.1038/s41598-022-24187-5 |
Ejemplares similares
-
A Long-Term and Large-Scale Real-World Study in Taiwan: Efficacy of Target Therapy in Stage IV Colorectal Cancer
por: Huang, Sheng-Chieh, et al.
Publicado: (2022) -
Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery
por: Yang, Kai-Lin, et al.
Publicado: (2013) -
Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage
por: Li, Linfang, et al.
Publicado: (2021) -
Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
por: You, Weiqiang, et al.
Publicado: (2020) -
The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels
por: Xie, Hai-Lun, et al.
Publicado: (2019)